BALI demo plant for co-production of bioethanol and green chemicals

Transcription

1 BALI demo plant for co-production of bioethanol and green chemicals Gudbrand Rødsrud Technology Director Business Development Nordic Baltic Bioenergy 2013, Oslo

2 Borregaard IPO Formerly owned 100 % by Orkla ASA strategic focus of Orkla shifted to branded consumer goods Successfully listed on the Norwegian stock exchange on October 18th 2012 Market cap 2.3 billion NOK (400 mill USD) > shareholders

3 Global presence An international business with global customers Borregaard Turnover: NOK 3,6 bill 1050 employees in 17 countries Head office Sales office Production

4 Existing value chains... Cellulose Bleached cellulose Dried cellulose Sarpsborg sulfite mill Ethanol Vanillin Lignin External sulfite mills Lignin BALI plant Lignin Cellulose Sugar

5 ... extended with BALI technology Cellulose Bleached cellulose Dried cellulose Sarpsborg sulfite mill Ethanol Vanillin Lignin External sulfite mills Lignin BALI plant Lignin Cellulose Sugar BALI Borregaard Advanced Lignin

6 BALI project in a nutshell The main goal in the BALI project is efficient pretreatment and enzymatic hydrolysis of biomass to sugar hydrolysates competitive production of high quality lignosulfonates from new feedstocks Cellulose with low lignin content Sugar in solu@on Bagasse Water soluble lignin

7 BALI demo unit operations Mechanical biomass handling Chemical pretreatment lignin cellulose hydrolysis sugar Ethanol, Chemicals Yeast Patents pending Chemical lignin processing Chemical processing BALI process

8 Mass balance of steam explosion pretreatment (only C/H/L shown) SE data from et al. BioRes 2008, 607. Data normalized to of bagasse used in BALI demo plant Data for BALI based on actual data from demo plant - only xylan/xylose considered in calcula@on of hemicellulose content

9 Mass balance of BALI pretreatment (only C/H/L shown) BALI achieves a good fractionation between cellulose and lignin SE data from Mar@n et al. BioRes 2008, 607. Data normalized to composi@on of bagasse used in BALI demo plant Data for BALI based on actual data from demo plant - only xylan/xylose considered in calcula@on of hemicellulose content

10 Scaling up the Borregaard BALI concept into demo scale First lab experiments Dec 2007 Funding secured Jan 2011 Demo plant operational Q Fully commissioned Jan 2013 Inaugurated Apr 2013 by minister of finance Sigbjørn Johnsen 24/7 operation with a total of 10 operators in 5 shifts Key figures 50 kg/h dry matter 800 m2 total area 140 MNOK (24 MUSD)

11 BALI demo plant philosophy Industrial demo plant continuous process automation instrumentation (1800 I/O's) Scale up 1000x previous lab scale 1/1000th of full scale De-risking test equipment verify mass balance samples for testing

12 BALI demo plant comissioned and now operational

13 BALI demo feedstock handling

14 BALI demo pretreatment, hydrolysis and lignin processing

15 BALI demo fermentation (30, 300 and 3000 L fermentors)

16 Commercialization BALI business model is to build and operate a production plant, preferably in cooperation with a partner First plant likely to be integrated into existing facility feedstock infrastructure opportunity for over-the-fence supply of sugar Ideal partner good knowledge of biorefinery value chains complementary R&D knowledge and capacity strategic interest in growing the bio-based industry willing to invest in a commercial plant Feedstock, location and timing of first BALI plant not yet decided Decision point for a commercial scale facility 2014

17 BALI demo plant technology status Demo plant operational (>100 MT biomass processed) Built on proven technology from a leading biorefinery (2 patents pending) Multifeedstock technology Efficient fractionation of cellulose and lignin yields clean hydrolysates Excellent add-on to 1G sugar mill BALI is the only concept with a commercially proven value added lignin

18 Funding and acknowledgement Construc,on of BALI demo plant 58 MNOK (10 MUSD, 7.8 MEUR) grant from Norway EuroBioRef 22 MNOK (3.9 MUSD, 3 MEUR) funding from FP7 through the EuroBioRef consor@um ( ) Biomass2Products 18 MNOK (3.1 MUSD, 2.4 MEUR) funding from the Norwegian Research Council ( ) New Norwegian Biorefinery 9 MNOK (1.6 MUSD, 1.2 MEUR) from the Norwegian Research Council ( ) NorZymeD 1.25 MNOK (0.22 MUSD, 0.17 MEUR) from the Norwegian Research Council ( ) The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/ ) under grant agreement n EuroBioRef